Enter OTP
Freiburg im Breisgau, Germany
Cost Of Living
Undergraduate Fees International Students
Post Graduate Fees International Students
The below information is required while
completing the university application :
Academic Qualification
– Applicants must hold a valid German Abitur or a recognized international equivalent (“Hochschulzugangsberechtigung”) to qualify for a bachelor-level Staatsexamen programme in medicine .
**Admission Process & Deadlines**
– Applications are submitted via hochschulstart.de. Only winter-semester entry is allowed for first-year entrants.
– Application deadlines: May?31 for earlier qualification, or July?15 for those completing by July; for later semesters: June?1–July?15 (winter), Dec?1–Jan?15 (summer) .
Competitive Admission (Numerus Clausus)
– Entry into medicine is numerus clausus (NC)—selection based on criteria like Abitur GPA, waiting time, and TMS (Test für Medizinische Studiengänge) results .
Know more
UHZ offers roles in cardiovascular medicine—for students, residents, and researchers—through positions like trainee doctors, clinical scientists, and research assistants, housed within its clinical research centre and specialty departments.
Dr. Leonardo Sacconi, an associated investigator in CRC 1425, was awarded a €2.65 million ERC Advanced Grant to support the “HeartCORE” project, which integrates functional and structural data to enhance predictions and understanding of cardiac arrhythmia .
UHZ appears in the Nature Index for Germany, reflecting its substantial contributions to high-impact international cardiovascular research and its strong collaborative output.
Secured an €11 million grant from the German Research Foundation to establish CRC 1425—focused on the heterocellular dynamics of cardiac lesion scar formation and driving translational innovations in diagnosis and therapy of heart disease.
A novel catheter design featuring two balloons and dual lumens to regulate reperfusion after ischemia–reperfusion events. This patented device aims to reduce fatal arrhythmias by enabling controlled blood flow during cardiac recovery. It earned the Most Promising Technology award at MedFIT 2023 .
Designed in UHZ’s Cardiovascular Surgery department, the CARL method utilizes the Controlled Integrated Resuscitation Device to deliver automated, parameter-controlled whole-body reperfusion after prolonged cardiac arrest. Tested in animal models and patients, it has achieved significant improvement in consciousness recovery.
Developed by the Vascular Immunology team, this breakthrough therapeutic—now backed by two international patents—inhibits the interaction between integrin Mac‑1 and CD40L. It selectively limits pathological inflammation, showing promise in protecting against atherosclerosis, sepsis, and adverse cardiac remodeling post-infarction.
Embark on your educational journey with confidence! Our team of admission experts is here to guide you through the process. Book a free session now to receive personalized advice, assistance with applications, and insights into your dream school. Whether you're applying to college, graduate school, or specialized programs, we're here to help you succeed.
